JEFFREY TURGEON: Open Payments
NPI 1437116399 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 75 payments from 11 companies in 2025. Trend: 2023 $960 · 2024 $942 · 2025 $1,559
Food & beverage: $1,338Education: $221
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $342 |
| Vanda Pharmaceuticals Inc. | 11 | $277 |
| ABBVIE INC. | 20 | $242 |
| Janssen Pharmaceuticals, Inc | 9 | $171 |
| Alkermes, Inc. | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 5 | $115 |
| Neurocrine BioSciences, Inc. | 6 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: FANAPT, VRAYLAR, INVEGA SUSTENNA, ARISTADA, INGREZZA, AUSTEDO XR, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
